Show simple item record

Brief report: updated efficacy and safety data from an integrated analysis of entrectinib in locally advanced/metastatic ROS1 fusion-positive non-small-cell lung cancer

dc.contributor.authorFan, Y.en
dc.contributor.authorDrilon, A.en
dc.contributor.authorChiu, C. H.en
dc.contributor.authorLoong, H. H. F.en
dc.contributor.authorSiena, S.en
dc.contributor.authorKrzakowski, M.en
dc.contributor.authorDziadziuszko, R.en
dc.contributor.authorZeuner, H.en
dc.contributor.authorXue, C.en
dc.contributor.authorKrebs, Matthew Gen
dc.date.accessioned2024-02-21T13:03:28Z
dc.date.available2024-02-21T13:03:28Z
dc.date.issued2023en
dc.identifier.citationFan Y, Drilon A, Chiu CH, Loong HHF, Siena S, Krzakowski M, et al. Brief Report: Updated Efficacy and Safety Data From an Integrated Analysis of Entrectinib in Locally Advanced/Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer. Clinical lung cancer. 2023 Dec 7. PubMed PMID: 38245456. Epub 2024/01/21.en
dc.identifier.pmid38245456en
dc.identifier.doi10.1016/j.cllc.2023.12.001en
dc.identifier.urihttp://hdl.handle.net/10541/626875
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.cllc.2023.12.001en
dc.titleBrief report: updated efficacy and safety data from an integrated analysis of entrectinib in locally advanced/metastatic ROS1 fusion-positive non-small-cell lung canceren
dc.typeCase Reporten
dc.contributor.departmentDivision of Cancer Sciences, The University of Manchester, and The Christie NHS Foundation Trusten
dc.identifier.journalClinical Lung Canceren
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record